Director Sara Nayeem to resign from IMARA board effective Nov 15, 2021

Enliven Therapeutics, Inc.

Dr. Sara Nayeem announced resignation from the board of directors on October 21, 2021.
Resignation effective November 15, 2021, due to a change in her employment.
No replacement announced; board size will decrease by one member.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Sara Nayeem

director

ELVN · Enliven Therapeutics, Inc.

Effective: 2021-11-15
Filed: October 25, 2021, 7:59 PM ET

On October 21, 2021, Dr. Sara Nayeem announced that she will resign from the board of directors of IMARA Inc., effective November 15, 2021, due to a change in her employment.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sara Nayeem resigned as director at Enliven Therapeutics, Inc..

Action: resigned
Role: director

Exact text from the filing

On October 21, 2021, Dr. Sara Nayeem announced that she will resign from the board of directors of IMARA Inc., effective November 15, 2021, due to a change in her employment.

View on SEC.gov

Enliven Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001564590-21-051756

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.